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b-Lactamase and penicillin-binding protein PBP20 mediate staphylococcal
resistance to b-lactam antibiotics, which are otherwise highly clinically
effective. Two repressors (BlaI and MecI) regulate expression of these
inducible proteins. Here, we present the first solution structure of the
82 amino acid residue DNA-binding domain of Bacillus licheniformis BlaI
which is very similar in primary sequence to the medically significant
Staphyloccocal BlaI and MecI proteins. This structure is composed of a
compact core of three a-helices and a three-stranded b-sheet typical of
the winged helix protein (WHP) family. The protein/DNA complex was
studied by NMR chemical shift comparison between the free and com-
plexed forms of BlaI. Residues involved in DNA interaction were identi-
fied and a WHP canonical model of interaction with the operators is
proposed. In this model, specific contacts occur between the base-pairs
of the TACA motif and conserved amino acid residues of the repressor
helix H3. These results help toward understanding the repression and
induction mechanism of the genes coding for b-lactamase and PBP20.
q 2003 Elsevier Ltd. All rights reserved.
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Introduction
To date, the nosocomial spread of the bacterial
strains resistant to antibiotics has become a major
public health concern.1,2 Many strains have become
resistant to b-lactam antibiotics, by either (i) the
expression of a specific hydrolase, the b-lactamase,
which inactivates b-lactam antibiotics by hydro-
lyzing their endocyclic amide bond, or (ii) the
production of an alternative transpeptidase
penicillin-binding protein (PBP20), insensitive to
penicillin inhibition.3 Although b-lactamase and
PBP20 have different structures and functions,
their synthesis is regulated by a similar repression
mechanism.
The expression of the b-lactamase, BlaZ in
Staphylococcus aureus or BlaP in Bacillus licheniformis
749/I, is under the control of three genes: blaI,
blaR1 and blaR2. The first two genes are clustered
in an operon and form a divergon with the blaZ/
blaP gene (Figure 1A). The blaR2 gene is not linked
to the divergon, and it has not been identified yet.4
The BlaR1 membrane-bound protein is a penicillin
receptor, which detects the presence of the
b-lactam antibiotic outside the cell.5 BlaI is a cyto-
plasmic protein, which specifically recognizes
DNA operator sequences in the intergenic region
between the blaP/blaZ and blaI-blaR1 genes (Figure
1A). In absence of a b-lactam antibiotic, BlaI
is bound to its operator sequence as a dimer
and acts as a repressor for the blaP/blaZ gene
expression. The presence of b-lactam antibiotics
leads to the acylation of BlaR15 and in turn to the
transmission of an intracellular signal whose final
target is BlaI itself. Consequently, BlaI is released
from its operator and this leads to a high level
of b-lactamase production. The S. aureus and
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B. licheniformis BlaI repressors are known to
form dimers and multimers in solution, and are
composed of two domains.6 The N-terminal
domain (BlaI-NTD) is involved in the DNA recog-
nition and the C-terminal domain (BlaI-CTD) is
responsible for BlaI dimerization. The two domains
of the B. licheniformis BlaI repressor can be sepa-
rated by papain digestion. BlaI-NTD is still able to
bind its operator with reduced affinity, but has
completely lost its ability to dimerize.7
In the methicillin-resistant S. aureus strain, the
low-affinity penicillin-binding protein PBP20 (or
PBP2a or MRSA) is encoded by the mecA gene.
Production of this protein is regulated by similar
sensory-transducer and repressor proteins as b-lac-
tamase production. The presence of MecR2 is also
postulated in the induction mechanism of mecA
(Figure 1(A)). The S. aureus BlaI and MecI repres-
sors are 60% identical when compared to each
other and 31–41% identical when compared to the
B. licheniformis BlaI repressor, respectively. The per-
centages of highly conserved amino acid residues
in the transducers are 30 for the S. aureus BlaR,
S. aureus MecR pair, 21 for the B. licheniformis BlaR,
S. aureus BlaR pair and 23 for the B. licheniformis
BlaR, S. aureus MecR pair.8 To date, no structural
data concerning BlaI, MecI or homologous proteins
have been reported.
DNase footprinting experiments with the BlaI
and MecI proteins revealed that in the correspond-
ing strains the different repressors recognize 22
base-pair long symmetry dyads, which exhibit a
high degree of similarity (Figure 1B). Furthermore,
S. aureus BlaI and MecI were shown to corepress
PBP20 and b-lactamase production.9,10 These
studies suggest that BlaI and MecI share the same
structural properties concerning DNA interaction.
The inactivation mechanism is, however, different
for the two repressors, allowing a fine regulation
process.9,11
To elucidate the BlaI/MecI interaction with its
DNA operator sequence, and its mechanism of
inactivation during the induction process, the
structural study of the B. licheniformis BlaI has
been undertaken by heteronuclear NMR spectro-
scopy. Here, we report (i) the high-resolution solu-
tion structure of the B. licheniformis BlaI-NTD,
(ii) the characterization of the BlaI interaction zone
with its DNA operator by chemical shift mapping,
(iii) a general DNA interaction model describing
the interaction of BlaI/MecI with their DNA opera-
tors. These results provide important insights
about the regulation mechanism of the genes
encoding b-lactamase and PBP20.
Results and Discussion
BlaI repressor belongs to the WHP family
The full-length B. licheniformis BlaI protein was
cleaved using papain digestion. The position of
the unique cleavage site, unambiguously obtained
from N-terminal sequencing and matrix-assisted
laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry was localized
between the residues Ser82 and His83. The full-
length BlaI protein as well as the N-terminal
domain 1–82 (BlaI-NTD) were studied by hetero-
nuclear NMR. The similarity between the BlaI-
NTD and BlaI 15N-heteronuclear single quantum
coherence (HSQC) spectra (Figure 2) demonstrates
Figure 1. Schematic representation of bla and mec operon organization in B. licheniformis and S. aureus. A, The mec
and bla regulators, mecR1-mecI and blaR1-blaI, respectively, encode inducer-repressor systems with a high level of
sequence similarity. The S. aureus BlaI and MecI repressors are 60% identical when compared to each other and 31–
41% identical when compared to the B. licheniformis BlaI repressor. The percentages of highly conserved amino acid
residues in the transducers are 30 for the S. aureus BlaR–S. aureus MecR pair, 21 for the B. licheniformis BlaR–S. aureus
BlaR pair and 23 for the B. licheniformis BlaR–S. aureus MecR pair.8 B, Alignment of B. licheniformis bla, S. aureus bla,
and S. aureus mec operators.
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Figure 2. Comparison of the 15N HSQC spectra at 25 8C of BlaI N-terminal domain (BlaI-NTD) and of full-length BlaI.
Left: BlaI-NTD spectrum with assignment obtained for residues 6–81. Right: spectrum of the complete protein BlaI.
Except for residue 81, all BlaI-NTD resonances are observed in the same positions, indicating that the N-terminal
part of the protein forms an independent and structured domain. The resonances corresponding to the C-terminal
domain (83–128) are poorly resolved and are mainly located in a region characteristic of extended structure.
Figure 3. NMR structures of BlaI-NTD (1–82). Secondary structures are colored: H1 in yellow, H2 in orange, H3 in
red and the three strands of the b-sheet in blue. Top: stereo view of the ribbon backbone diagram of the lowest-energy
structure. Bottom: stereo view of the backbone diagram of the 19 refined low-energy structures. Backbone heavy atoms
were used for superimposition.
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that the N-terminal part constitutes an indepen-
dent structural domain. Only a few resonances of
BlaI-NTD differ between the two spectra, and
those correspond to the residue neighboring the
cleavage site (Lys81). The resonances correspond-
ing to the C-terminal domain (82–128) are broad
and poorly resolved, suggesting that this domain
could be less structured or more mobile than the
N-terminal domain.
The BlaI-NTD structure was solved using two-
and multidimensional NMR spectroscopy, making
use of uniformly 15N, 13C/15N and 2H/13C/
15N-labeled proteins. Nearly complete 1H, 13C and
15N assignments were obtained using standard
resonance assignment procedures. The few missing
assignments correspond to the N and C-terminal
ends (residues 1–4, and 82).
For structure calculation, a total of 1252 inter-
proton, 110 dihedral and 97 chiral restraints were
used. The distance constraints contain 596 intra-
residue, 205 sequential, 87 medium-range, 145
long-range and 219 ambiguous correlations
derived from 2D, 3D, and 4D nuclear Overhauser
effect spectroscopy (NOESY) spectra. The dihedral
c and f angle restraints were deduced from
TALOS, using backbone chemical shift values. At
the final stage, 80 conformers were calculated, and
the conformers with the lowest-energy functions
were selected to be refined. A ribbon diagram of
the lowest-energy structure and a superposition of
the final ensemble of 19 simulated annealing struc-
tures are shown (Figure 3).
Ensemble analysis of BlaI-NTD backbone stereo-
chemical quality was done with NMR-
PROCHECK.12 Over 99% of the dihedral angles
were found in the most favored and additional
allowed regions of the Ramachandran plot. Struc-
tural conformations of residues 1–4 and 79–82 are
poorly defined, due to the lack of assignment for
residues 1–4 and 82, or to the small number of
NOE constraints for residues 79–81. Heteronuclear
NOEs (Supplementary Material) confirm that the
N and C-terminal parts of the protein are rather
mobile. For statistics, we consider only the rigid
core of BlaI-NTD (residues 5–78). For these resi-
dues, we obtained an average of 16.4 restraints
per residue. A good agreement with the exper-
imental restraints is reflected by the low exper-
imental energy level. There is no distance
restraints violation greater than 0.1 A˚. The back-
bone and heavy-atom root-mean-square deviation
(rmsd) values calculated for BlaI-NTD 5–78 with
respect to the mean coordinates are 0.63(^0.17),
and 1.07(^0.18) A˚, respectively. A summary of the
restraint and structural statistics is presented in
Table 1.
The BlaI-NTD 3D structure consists of a three-
stranded b-sheet (S1, Ser23-Asn25; S2, Leu57-
Glu62; and S3, Val65-Pro70) packed against three
a-helices (H1, Asp9-Lys20; H2, Thr26-Thr36; and
H3, Pro41-Lys53) arranged in the order H1-S1-H2-
T1-H3-S2-W1-S3. S2 and S3 form an antiparallel
hairpin (loop called wing W1: Gly63-Arg64) and
S1 is connected antiparallel to S3. T1 (Ser37-Ser40)
is a type I turn connecting H2 and H3. The a-
helices and the b-sheet form a well-defined and
compact core. This tertiary arrangement belongs
to the winged helix proteins (WHP) family, which
is a member of the DNA recognition helix-turn-
helix superfamily.13,14 Among the WHP, the relative
orientation of the secondary structures is variable
due to the differences in the length of the T1 turn
connecting H2 and H3, and in the length of the
wing W1. Comparison of the structure of BlaI-
NTD with other WHP proteins was made using
the DALI search algorithms.15 The most similar 3D
structures are those of E2F4, SMTB, ADAR1,
LexA, MarR, FokI, DTXR, and Genesis, all of them
being DNA recognition domains. It is interesting
to note that the MarR protein is also involved in a
mechanism of antibiotic resistance.16 Although no
sequence homology could be detected by primary
sequence similarity searches, all these proteins pre-
sent a central core similar to that of BlaI-NTD.
Whereas their helices can be of significantly differ-
ent lengths, angles between the three a-helices are
conserved. The main differences observed for
these proteins are localized in the wing region.
Some of the WHP proteins like Genesis have a
long and flexible W1 wing, as revealed by hetero-
nuclear NOE measurements.17 In the case of BlaI-
NTD, wing W1 is short (residues 63–64). Hetero-
nuclear NOE data (Supplementary Material) show
no particular mobility for residues neighboring
W1.
A high degree of sequence homology exists
between B. licheniformis BlaI and S. aureus MecI,
especially for the non-polar core residues. In par-
ticular, many of the buried residues forming the
core of the structure are identical or similar (BlaI/
MecI) between BlaI and MecI: (H1) Ala10, Val14,








Hydrogen bond restraints 0
Ambiguous restraints 219
Dihedral angle restraints 110
Chiral restraints 97
Average rms deviations from the mean coordinates (A˚)a,b
Backbone heavy-atoms: 0.63 ^ 0.17
All heavy-atoms: 1.07 ^ 0.18
Ramachandran analysis (%)b,c
Residues in most favoured regions: 85.6
Residues in additional allowed regions: 13.7
Residues in generously allowed regions: 0.2
Residues in disallowed regions: 0.5
a Statistics were made for residues 5–78 (see the text).
b Average for the 19 lowest-energy structures.
c Only non-Gly and non-Pro residues were assessed with
PROCHECK-NMR.
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Met15, Ile18, Trp19, (H2) Val/Ile29, Ile/Val30,
Glu32, Leu/Ile33, (H3) Ile44, Leu/Ile48, Leu51,
(b-sheet) Leu/Ile57, Tyr68, Ile72. Since there is no
deletion or insertion necessary to align BlaI and
MecI, the secondary structures predicted for MecI
have the same length as for BlaI. All these data
support the conclusion that MecI also belongs to
the WHP family, and that its fold is very close
to the BlaI structure.
DNA recognition by the repressors BlaI
and MecI
For some of the WHP proteins with a BlaI-NTD
similar fold listed above, the protein–DNA com-
plex has been investigated by X-ray crystallogra-
phy, NMR or computational tools.13 For all of
them, the same DNA interaction mode has been
reported. Helix H3, called the recognition helix, is
presented to the major groove of the DNA, and
makes specific contacts with the base-pairs. The
wings (in particular W1) and the protein N-term-
inal part also make contacts with the minor groove
of the DNA. Unlike this WHP canonical mode of
DNA recognition, the WHP RFX1 makes most of
the contacts with the DNA major groove via wing
W1.18 The so-called recognition helix H3 overlies
the minor groove, and there is no contact between
the N-terminal part of the protein and the DNA.
To investigate the BlaI DNA recognition mode,
the BlaI–DNA interaction surface was determined
using the NMR chemical shift perturbation
method. The method detects protein residues that
are interacting directly, or that undergo confor-
mational changes upon binding. 15N-HSQC spectra
of B. licheniformis BlaI-NTD were recorded with
increasing amounts of DNA for both the 30-mer
DNA corresponding to the B. licheniformis BlaI
operator op1, and a palindromic 24-mer DNA
based on the symmetric consensus sequence of the
mec and bla operators. Results obtained with the
palindromic 24-mer DNA are shown in Figure 4
and are similar to the results obtained with the
30-mer DNA (data not shown).
Since the 15N-HSQC spectra of DNA-free BlaI-
NTD, and of DNA-bound BlaI-NTD share many
similarities (Figure 4A), the amide 1H and 15N chemi-
cal shifts of the N-terminal domain of DNA-bound
Figure 4. Chemical shift mapping of BlaI-NTD in interaction with DNA. A, 15N HSQC spectra recorded at 25 8C. Left:
BlaI-NTD spectrum in absence of DNA. Right: BlaI-NTD/DNA complex spectrum. The 24-mer palindromic DNA was
added to the sample to reach a protein/DNAduplex ratio of 1/2. (B) Graph of the chemical shift variations between the
DNA free BlaI-NTD and the BlaI-NTD/DNA complex versus residue number. The vertical axis corresponds to ðld1Hl £
lgH=gNlþ ld15NlÞ measured on the spectra presented in A. Arrows represent amino proton resonances that have been
broadened and not assigned in the complexed form. The absence of a bar indicates the presence of a proline residue
or an unmeasured shift due to overlap. The limit between weak and strong chemical shift variations has been fixed
to 0.4 ppm.
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BlaI-NTD were assigned by reference to the free
protein assignments. This comparison shows that
BlaI-NTD does not undergo major structural
rearrangements upon binding to DNA. The 15N,
1H chemical shift and intensity changes for back-
bone amide groups are given (Figure 4B). Signifi-
cant chemical shift or intensity changes can be
observed in the protein N-terminal part (Ile7 and
Ser8), all along helix H3 (Ser40, Thr43, Met47,
Leu48, Arg50, Leu51, and Ile52), and in the
b-sheet, especially next to wing W1 (Asn25, His59,
His60, Lys61, Glu62, Val65, and Val67). All the resi-
dues affected upon binding can be highlighted on
the BlaI-NTD structure. They define a DNA-bind-
ing surface located on a single side of BlaI-NTD.
This surface can be superimposed nicely with the
positively charged region of the protein electro-
static surface (Figure 5A). The residues of the BlaI-
NTD N-terminal part that are affected upon bind-
ing demonstrate the functional importance of the
repressor N-terminal part in DNA-binding. This
result is consistent with former DNA footprinting
studies showing that a BlaI repressor mutant carry-
ing a six amino acid deletion (Lys3-Ser8) within its
N-terminal region had lost its ability to bind the
operator.7 Mutation of lysine 4 to alanine also
severely reduces the BlaI DNA-binding ability.19
The crucial role of the N-terminal domain and the
shape of the electrostatic and interaction surfaces
are not consistent with RFX1-DNA recognition
mode, where there is no interaction between the
N-terminal part of the protein and the DNA. On
the contrary, they are in good agreement with a
canonical WHP–DNA interaction, as described for
E2F4.20 Furthermore, the distances separating helix
H3, wingW1, and the N-terminal ends that interact
with DNA are quite equal for BlaI and E2F4. We
therefore propose a model for the interaction
between the repressors BlaI and MecI and their
operators by comparison with the structure of the
E2F4–DNA complex (Figure 5B). In this model,
helix H3 interacts with the major groove of the
operator. Other DNA–protein contacts occur via
wing W1 and in the N-terminal part. Precise pos-
ition of the contacts between the amino acid resi-
dues of BlaI and MecI and the base-pairs must
still be investigated via a high-resolution structure
of the DNA–repressor complexes.
Biological implication: insights about the BlaI
and MecI repression mechanism
It has been reported that BlaI and MecI could
corepress b-lactamase and PBP20 gene expression
in S. aureus.9 In the same way, B. licheniformis BlaI
interacts with S. aureus mec operator, as highlighted
by gel mobility-shift assay (C. V., unpublished
results). To explain this mec/bla corepression, the
sequence homology for both the repressors and
the DNA operator sequences of S. aureus and
B. licheniformis was investigated. The primary
structure alignment between B. licheniformis BlaI
and S. aureus MecI and BlaI (Figure 5D) shows
that all H3 residues pointing outside the protein,
and therefore probably implicated in DNA recog-
nition (Lys42, Thr46, Arg50 and Lys53), are totally
conserved among the BlaI and MecI repressors.
These residues are either positively charged or
able to form specific hydrogen bonds with the
base-pairs. The existence of a totally conserved
DNA palindromic motif (TACA) in the mec and
bla operators in S. aureus and B. licheniformis has
been highlighted previously (Figure 1).7 In our
interaction model, the conserved residues in BlaI
and MecI helix H3 make specific contacts with
this TACA motif (Figure 5C). Interestingly, this
model locates well-conserved positive residues
(His59, His60, and Lys61, next to W1) facing an
also conserved AT base-pair. Furthermore, locating
two BlaI-NTD monomers on the two symmetric
TACA motifs along the operator places the C-term-
inal parts of the two monomers pointing in a con-
venient orientation for dimerization contacts.
Thus, we propose a repression mechanism, in
which the repressor helix H3 makes specific con-
tacts with the TACA motif of the operator
sequence. This model is able to explain the core-
pression of the mec and bla genes.
Although the S. aureus and B. licheniformis BlaI
share the same DNA-binding features, they exhibit
different induction mechanisms. In S. aureus, the
presence of the b-lactam inducer outside the cell
results in the proteolytic cleavage of the repressor
between residues N101 and F102,21 leading to the
loss of its ability to dimerize. As pointed out
above, the BlaI-NTD 3D-structure is not or slightly
modified when compared to that of the wild-type
BlaI, whereas the decrease of affinity between BlaI
and BlaI-NTD in B. licheniformis is about 500–1000
times.7 The SmtB Zn(II) sensing metallo-regulated
repressor is a WHP whose DNA-binding affinity
is in the same range as BlaI–DNA affinity. The
binding of a zinc ion to its C-terminal domain pro-
motes the disassembly of the SmtB–DNA complex
through a loss of affinity of about 1000.22,23 The
binding of a co-activator to the C-terminal domain,
as in SmtB, is not the only way to inhibit the
repressor activity of a winged-helix transcriptional
regulator. For example, in the case of Escherichia
coli MarR, the binding of two salicylate groups
close to the DNA-binding a-helix inhibits the
MarR activity.16 To investigate the role of the
C-terminal domain in BlaI–DNA interaction, a
chemical shift mapping experiment was carried
out for the dimeric full-length BlaI in the same con-
ditions as for the monomeric BlaI-NTD
(Supplementary Material). Two interesting obser-
vations can be derived from this study. First, a
similar chemical shift perturbation pattern is
obtained for the residues of the N-terminal
domain. Second, no significant modifications of
the resonances of the C-terminal domain are
observed. This suggests that the interaction mode
between BlaI-NTD and the DNA is not influenced
by the presence of the C-terminal domain. The
BlaI/MecI dimerization C-terminal domain is,
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however, essential to obtain a DNA-binding pro-
tein of high affinity, probably placing the two
DNA-binding domains in a favorable
conformation for DNA contacts.
Conclusion
The 3D solution structure of B. licheniformis BlaI
DNA-binding domain presented in this study
reveals that BlaI is a member of the WHP family.
S. aureus BlaI and MecI share also a similar WHP
fold. Chemical shift mapping experiments high-
lighted that BlaI presents the canonical DNA
recognition mode. The C-terminal part of the pro-
tein is involved in dimerisation, but not in DNA
interaction. The N-terminal part is a winged helix
motif, interacting via its N-terminal part, helix H3
and wing W1. A model of the BlaI/MecI DNA
interaction is proposed. In this model, specific
contacts occur between the base-pairs of the
TACA motif and conserved amino acid residues of
the repressors helix H3. These results help under-
standing the mechanism by which the BlaI/MecI
repressor regulates blaP/blaZ/mecA expression.
Materials and Methods
Plasmids and DNA manipulations
PET22b (Novagen) was used as vector for the over-
expression of the BlaI and BlaIGM2 products. The
construction of plasmids pET22bblaIWT and pET22b-
blaIGM2 has been described.4 The GM2 mutation
(M97V98/IL) is located in the C-terminal domain of BlaI.
For BlaI-NTD production, the GM2 mutant was pre-
ferred due to its better over-expression yield.
Figure 5. Comparison of the region involved in the protein/DNA complex for E2F4 and BlaI-NTD. A, Electrostatic
surface of BlaI and surface mapping of the region affected by the DNA interaction. On top, ribbon representation of
BlaI-NTD structure in a front and back orientation. In the middle, surface electrostatic potential is colored in red (posi-
tive) and blue (negative). The calculations were performed using the Swiss-PDB viewer (version 3.7). At the bottom,
chemical shift variations ðld1Hl £ lgH=gNlþ ld15NlÞ superior to 0.4 ppm (see Figure 4B) are indicated in red on the
BlaI-NTD surface. B, Structure of E2F4/DNA complex.20 Side-chains involved in a hydrogen bond with the DNA are
indicated in red and the H-bonds in green. Helix H3 forms direct H-bonds with the bases of the DNA (Arg56 and
Arg57) as well as the N terminus part (Arg17). The winged helix and the turn between H1 and H2 form H-bonds
with the phosphate and the sugar of the DNA (Lys44 and Asn77). Note that the residue numbering of E2F4 is quite
different from that of BlaI where the H3 helix extends between the residues 41 and 53. C, Interaction model of the com-
plex BlaI-NTD/DNA derived from the E2F4/DNA complex. BlaI-NTD structure was superimposed with E2F4 struc-
ture. Totally conserved nucleotides presented in the consensus sequence of Figure 1 are colored in green D, Sequence
alignment of B. licheniformis BlaI, and S. aureus BlaI and MecI. Residues indicated in blue correspond to amino acid
residues conserved between BlaI of B. licheniformis and S. aureus. Residues indicated in red are conserved between
BlaI and MecI of S. aureus. The highlighted residues correspond to the residues affected by the DNA interaction (deter-
mined by the B. licheniformis BlaI chemical shift mapping).
NMR Structural Studies of the BlaI Repressor 717
Protein overexpression and purification
The uniformly 15N-labeled BlaI sample was prepared
by growing E. coli BL21(DE3) pLys containing the corre-
sponding recombinant pET22b plasmid in an optimal
M9 minimal medium without Casamino acids. In this
medium, the only source of nitrogen was
[15N]ammonium chloride and the culture medium con-
tained 18 mM 15NH4Cl, 35 mM unlabeled glucose,
100 mg/ml of ampicillin, 30 mg/ml of chloramphenicol,
5 mM biotin, 7 mM thiamin, 13 mM FeSO4, 0.5 mM
MgSO4, 0.01% (w/v) cholin chloride, 0.001% (w/v) folic
acid, 0.002% (v/v) pyridoxal, 0.0001% (w/v) riboflavin
and 0.01% (w/v) niaccinamid. Cells were grown at
37 8C to an A600 nm of 0.7 and isopropyl b-D-galactosidase
(IPTG) was then added to a final concentration of 1 mM.
Overnight-induced cells were then harvested by cen-
trifugation, lysed and purified.4 The final yield of puri-
fied 15N-labeled protein was 6 mg per liter of cell
culture and the isotopic labeling was 94% as determined
by mass spectrometry.
The uniformly 15N/13C-labeled BlaIGM2 sample was
produced according to the same procedure, apart from
the fact that M9 minimal medium was replaced by the
Silantes OD2-CN medium (Silantes GmbH, Gollier-
strasse 70C, D-80339 Munchen). The final yield of puri-
fied labeled protein was 20 mg/l of cell culture and the
percentage of isotopic labeling was 99%.
Uniformly 15N/13C/2H-labeled BlaIGM2 sample was
produced using the optimized M9 medium in which
water had been replaced by 2H2O and with
15NH4Cl and
13C glucose concentrations of 18 mM and 10 mM,
respectively. The final yield of purified labeled protein
was 4 mg per liter of cell culture and the percentage of
deuterium labeling was approximately 75%.
Papain digestion and BlaI-NTD purification
Purified BlaI or BlaIGM2 were dialysed against a buf-
fer containing 50 mM Hepes (pH7), 100 mM NaCl,
1 mM EDTA and was digested overnight using 1%
mol/mol papain at 28 8C. After this time, the cleavage
was complete and the protein digest was applied to an
S-Sepharose-Fast-Flow column equilibrated in buffer A
(50 mM Hepes (pH7), 100 mM NaCl, 1 mM EDTA, 5%
(v/v) glycerol). BlaI-NTD was eluted with 1 M NaCl in
the same buffer. The BlaI-NTD containing fractions were
pooled, dialyzed exhaustively against 50 mM sodium
phosphate (pH7.6), 200 mM KCl, 1 mM NaN3, 0.1 mM
Pefabloc and then concentrated to a final
protein concentration of 0.5 mM by ultrafiltration with a
Centricon (cut-off 5 kDa, Amicon, Brussels, Belgium).
Amino N-terminal sequencing of BlaI-NTD was
carried out using a Procise 492 pulsed liquid phase pro-
tein sequencer (Applied Biosystems) with 20–30 pmol
of protein.
Band-shift assays
Gel retardation experiments were realized as
described.24
NMR sample preparation
NMR samples of BlaI-NTD were prepared at a concen-
tration of 0.75 mM in 75 mM sodium phosphate buffer
(90% H2O, 10%
2H2O), 300 mM KCl, pH 7.6. For the full-
length protein, an extensive microdrop study was car-
ried out to optimize the buffer conditions and prevent
aggregation observed at high concentration.25 Aggrega-
tion was avoided by adding 300 mM glycine and
240 mM NaCl to the buffer used for BlaI-NTD. BlaI
samples were thus prepared in the same condition at
0.75 mM for 15N-labeled BlaI, 0.5 mM for 15N/13C-labeled
BlaI, and 0.5 mM for 15N/13C/2H-BlaI. For protein inter-
action studies, two DNA sequences were chemically syn-
thesized: a 30-mer corresponding to the B. licheniformis
BlaI operator op1 50-GAA AGT ATT ACA TAT GTA
AGA TTT AAA TGC-30, and a consensus palindromic
24-mer DNA: 50-AAA GTA TTA CAT ATG TAA TAC
TTT-30. DNA was dissolved in the same buffer as the
protein. Samples of 15N BlaI and 15N/13C BlaI-NTD were
prepared at a concentration of 0.1 mM. DNA solution
was progressively added by amounts of 20 ml to reach
BlaIdimer/DNAduplex ratios of 0.5, 1.0, 1.5 and 2.0, and a
BlaI-NTD/DNAduplex ratios of 0.5, 1.0, 1.5, 2.0, and 2.5.
NMR spectroscopy
For sequential assignment, standard triple resonance
experiments were carried out on 15N and 15N/13C-labeled
samples of BlaI-NTD: HNCA, HNCO, HN(CA)CO,
CBCANH, and CBCA(CO)NH for backbone assignment
and (H)C(CO)NH-TOCSY, H(CCO)NH-total correlated
spectroscopy (TOCSY) for aliphatic side-chain assign-
ment. For resonance assignment of aromatics, HSQC
and H(C)CH-TOCSY experiments with the 13C carrier
set to 125 ppm, and 2D-NOESY spectrum performed on
a sample dissolved in 2H2O were used. An HNCA exper-
iment was performed on a 15N/13C/2H-labeled sample of
BlaIGM2 to confirm the assignment of the N-terminal
part in the full-length protein.
Inter-protons restraints were derived from NOESY
spectra: 2D-NOESY, 3D 15N-edited NOESY-HSQC, regu-
lar 3D 13C-edited NOESY-HSQC, 3D 13C-edited NOESY-
HSQC optimized for CH groups and 4D 13C-edited
HSQC-NOESY-HSQC.26 Mixing times were set to 120 ms.
For chemical shift mapping, 15N-HSQC, 13C-HSQC
optimized for aromatics and CT-HSQC were performed
at different protein/DNA ratios.
All NMR experiments were performed on Varian
INOVA 600 and INOVA 800 spectrometers, both
equipped with a triple-resonance (1H, 15N, 13C) probe
and shielded z-gradients. The temperature was set to
25 8C. All triple-resonance experiments used the pulse
sequences provided by the Varian Protein Pack.† All
data processing, peak picking and peak intensity
measurements were performed using the FELIX pro-
gram version 2000 (Accelrys).
Structure calculation
The NOE distance restraint calibration was performed
using cross-relaxation volumes between atoms of known
separation in rigid parts of the molecule. A factor of 35%
was added to the resulting upper distance, to account for
the inherent uncertainty in the distance calculation. Clas-
sical pseudo atoms corrections were applied. The lower
distance limit was set to the sum of the van der Waals
radii of the two protons. Assignment, restraint gener-
ation, and structure calculation were performed itera-
tively. Restraints that were violated, resulting from
† ftp.nmr.varian.com
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misassignments or overlapped peaks, were corrected
after the first steps of calculation.
The c and f angles calculated by TALOS from back-
bone chemical shift values were used as constraints
with lower and upper bounds of ^208.27 Structure calcu-
lation was carried out using the Discover programs
(Accelrys) interfaced to INSIGHTII for visualization and
analytical purposes. The force-field used was AMBER.28
The structure determination protocol used a simulated
annealing calculation starting from randomized
Cartesian coordinates to explore the conformational
space, and a restrained molecular dynamics calculation
to refine each structure as described.29
Data Bank accession numbers
Chemical shift assignments of BlaI-NTD have been
deposited with BioMagResBank (accession number
5873). The coordinates of the 19 BlaI-NTD refined struc-
tures have been deposited in the Protein Data Bank
under the accession code 1P6R.
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